Lataa...
Aldo-keto Reductase Family 1 Member C3 (AKR1C3) Is a Biomarker and Therapeutic Target for Castration-Resistant Prostate Cancer
Current endocrine treatment for advanced prostate cancer does not result in a complete ablation of adrenal androgens. Adrenal androgens can be metabolized by prostate cancer cells, which is one of the mechanisms associated with progression to castration-resistant prostate cancer (CRPC). Aldo-keto re...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
ScholarOne
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563708/ https://ncbi.nlm.nih.gov/pubmed/23196782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00296 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|